Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,265
archived clinical trials in
Crohns Disease

A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Gastro One
mi
from
Germantown, TN
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Professional Quality Research, Inc.
mi
from
Austin, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Professional Quality Research, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Diagnostic Clinic of Houston
mi
from
Houston, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Diagnostic Clinic of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Houston Hospital for Specialized Surgery (Endoscopy only)
mi
from
Houston, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Houston Hospital for Specialized Surgery (Endoscopy only)
mi
from
Houston, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Baylor Clinic (Drug Storage)
mi
from
Houston, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Baylor Clinic (Drug Storage)
mi
from
Houston, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Baylor College of Medicine - Baylor Medical Center
mi
from
Houston, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Baylor College of Medicine - Baylor Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Ertan Digestive Disease Center
mi
from
Houston, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Ertan Digestive Disease Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Memorial Hermann Hospital
mi
from
Houston, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
University of Texas Health Science Center at Houston
mi
from
Houston, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
University of Texas Medical School in Houston
mi
from
Houston, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
University of Texas Medical School in Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Physicians Endoscopy Center (Colonoscopy)
mi
from
Houston, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Physicians Endoscopy Center (Colonoscopy)
mi
from
Houston, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Texas Digestive Disease Consultants
mi
from
Southlake, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Texas Digestive Disease Consultants
mi
from
Southlake, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
One Step Diagnostic (X-Ray)
mi
from
Sugar Land, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
One Step Diagnostic (X-Ray)
mi
from
Sugar Land, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Pioneer Research Solutions, Inc. (Admin. Office)
mi
from
Sugar Land, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Pioneer Research Solutions, Inc. (Admin. Office)
mi
from
Sugar Land, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Pioneer Research Solutions , Inc
mi
from
Sugarland, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Pioneer Research Solutions , Inc
mi
from
Sugarland, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Digestive Health Specialists of Tyler
mi
from
Tyler, TX
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Digestive Health Specialists of Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
University of Utah HSC
mi
from
Salt Lake City, UT
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
University of Utah HSC
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Virginia Commonwealth University
mi
from
Richmond, VA
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
VCU Medical Investigational Drug Service (IDS)
mi
from
Richmond, VA
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
VCU Medical Investigational Drug Service (IDS)
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Concord Repatriation General Hospital
mi
from
Concord,
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Concord Repatriation General Hospital
mi
from
Concord,
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Birmingham, AL
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Research Site
mi
from
Dithan, AL
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Research Site
mi
from
Dithan, AL
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Research Site
mi
from
Lowell, AR
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Research Site
mi
from
Lowell, AR
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Jacksonville, FL
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Miami, FL
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Hammond, LA
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Hammond, LA
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Chevy Chase, MD
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Rochester, MN
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Mexico, MO
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Mexico, MO
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Egg Harbor Township, NJ
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Great Neck, NY
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Charlotte, NC
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Wilmington, NC
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Germantown, TN
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Nashville, TN
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
San Antonio, TX
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Logan, UT
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Logan, UT
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Ogden, UT
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Ogden, UT
Click here to add this to my saved trials
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Research Site
mi
from
Kurralta Park,
AMG 827 in Subjects With Moderate to Severe Crohn's Disease
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Research Site
mi
from
Kurralta Park,
Click here to add this to my saved trials
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Birmingham, AL
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Hammond, LA
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Hammond, LA
Click here to add this to my saved trials
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Chevy Chase, MD
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Rochester, MN
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Mexico, MO
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Mexico, MO
Click here to add this to my saved trials
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Great Neck, NY
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Charlotte, NC
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
Nashville, TN
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated:  12/14/2015
Clinical Research Facility
mi
from
San Antonio, TX
Safety Study in Subjects With Crohn's Disease
A Long-term Assessment of Safety and Efficacy of AMG 827 Treatment in Subjects With Crohn's Disease
Status: Enrolling
Updated: 12/14/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials